Oligonucleotide-based Gene Therapy for Cardiovascular Disease Are Oligonucleotide Therapeutics Novel Cardiovascular Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|1|1|15-23

ISSN： 1389-4501

Source： Current Drug Targets, Vol.1, Iss.1, 2000-07, pp. : 15-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oligonucleotide-Based Molecular Therapy for Restenosis after Angioplasty

By  

Current Drug Targets, Vol. 4, Iss. 8, 2003-11 ,pp. : 613-618

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Delivery, Intracellular Trafficking, and Biological Effectiveness of Oligonucleotide-Based Therapeutics Executive Editor: A. Mescalchin and G. Sczakiel]

By  

Current Pharmaceutical Design, Vol. 14, Iss. 34, 2008-12 ,pp. : 3601-3602

Bentham Science Publishers

Access to resources Recommend Favorite

Antisense oligonucleotide therapeutics

By Bennett C.F.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 3, 1999-03 ,pp. : 255-255

Informa Healthcare

Access to resources Recommend Favorite

Antisense Anticancer Oligonucleotide Therapeutics

By  

Current Cancer Drug Targets, Vol. 1, Iss. 3, 2001-01 ,pp. : 177-196

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy in Cardiovascular Disease: Current Status

By Francis S.C.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 1, 2001-01 ,pp. : 55-66

Adis International

Access to resources Recommend Favorite